Market Survey on Personal Genome Testing Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Personal Genome Testing Market including Multi-Targeted Testing, Non-Targeted Testing, and Targeted Testing Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Personal Genome Testing Market Outlook (2022-2032)
[323 Pages Report] The global personal genome testing market is forecast to be appraised at US$ 4,468 Million by 2032, up from US$ 1,545.5 Million in 2022, advancing at a CAGR of 10.1% during the forecast period.
Attributes
Details
Personal Genome Testing Market Size (2022)
US$ 1,545.5 Million
Personal Genome Testing Market Size (2032)
US$ 4,468 Million
Personal Genome Testing Market CAGR (2022 to 2032)
10.1%
The advancements in the field of genetic testing, along with its wide usage in pharmacogenomics and toxicogenomic, drives the demands for personal genome testing. Increasing deployment of paternity testing, maternity testing, and prenatal testing promotes personal genome testing market growth.
The increased and developing awareness among healthcare professionals regarding the efficacy of these diagnostics owing to strong testing volumes ordered and managed by non-geneticists surges the adoption of personal genome testing.
Lifestyle-based and nutrition-based genetic tests are widely available for aiding diet and lifestyle plans among consumers, increasing demand for personal genome testing. The accuracy and reliable technology of genetic testing, and the growing awareness about its benefits, propels the personal genome testing market share.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Key Factors that Drive the Personal Genome Testing Market?
With the expansion of DTC genetic tests' application areas, the market share for personal genome testing increases. The market for personal genome testing is being expanded by businesses that provide DTC tests for use in continuing research, sports, nutrition, and other areas.
The range of services offered by genetic testing, such as data security, identification of ancestors, race and nature of family, increasing its usage in clinical practices, surges demand for personal genome testing.
The low cost value of genome testing across clinics, ranging from US$ 99 to US$ 2000, drives the demand for personal genome testing. Rising prevalence of genetic diseases related to genotype, phenotype, or mutation, and its need for detection and prevention propels the personal genome testing market growth.
The ability to detect genetic abnormalities in the early gestation period of 8 to 10 weeks surges the demand for personal genome testing. Growing R&D activities, along with government initiatives in the field, escalates the adoption of personal genome testing.
Increasing awareness and discoveries in the field of genetic testing, as well as the option to determine the sex of a fetus, broadens the personal genome testing market share. Descriptive information regarding analytical validity and clinical validity of the tests offered by the service provide, increases the demand for personal genome testing.
The requirement for identification and addressing of specific needs, personalized direct-to-consumer genetic tests, escalates the personal genome testing market size. Favorable reimbursement policies and increasing coverage for preventative genetic testing elevate the personal genome testing market share.
What are the Restraints of the Personal Genome Testing Market?
Due to the shortage of trained professionals, end users face significant issues in analyzing genomic data, hindering the personal genome testing market growth. Rigid regulatory requirements for product approvals are expected to hamper the demand for personal genome testing.
The personal genome testing market size is further obstructed owing to standardization concerns of genetic testing-based diagnostics.
Furthermore, the unavailability of doctors and genetic counselors, along with closing of test-running laboratories leading to disruption, limitation and challenges during the pandemic, hampered the adoption of personal genome testing.
Scepticism and criticism regarding genetic testing from healthcare professionals, owing to lack of evidence, thwarts the personal genome testing market share.
The desire for personal genome testing is curbed by the loss of discretion and control over customers' genetic material, as well as the risk that testing procedures could lead to a third party accessing clients' DNA information.
Find your sweet spots for generating winning opportunities in this market.
What are the Scopes of the Personal Genome Testing Market?
Unexplored emerging markets in developing economies and a high number of customers opting for online genetic testing are anticipated to promote the global personal genome testing market growth.
Moreover, the adoption of personal genome testing increases owing to the growth in the personalized medicine market, especially among the pharmaceutical companies. The shift of focus from clinical science to bioinformatics, and the increasing popularity of these techniques, increases the demand for personal genome testing.
Increased efficiency, accuracy, and new innovations and techniques further propel the demand for personal genome testing.
How will the North American Personal Genome Testing Market Grow?
North America holds the leading position in the personal genome testing market share, with a revenue of 37.3%.
This is owing to the rise in cases of genetic diseases and an increasing demand for technologically advanced medical equipment for treatment. The availability of a substantial number of key players dealing with genetic tests in this region surges the demand for personal genome testing.
High awareness about at-home testing among the U.S. population promotes the global personal genome testing market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What is the Europe Personal Genome Testing Market Outlook?
Europe has the second leading personal genome testing market share, with a revenue share of 26%.
The rising demand for technologically advanced medical equipment for treatment in this region promotes personal genome testing market growth.
The presence of key players, as well as new players entering the market causing competition, secures the expansion of the personal genome testing market size.
What is the Growth Outlook for the Asia Pacific Personal Genome Testing Market?
Due to rising knowledge of the advantages of genetic testing, the personal genome testing market share is predicted to increase in Asia-Pacific. Personal genome testing is becoming more popular as a result of growing awareness of numerous genetic illnesses and an increase in their prevalence in this area.
Rapid development of healthcare infrastructures across Asian countries further promotes market growth.
How is the Start-up Ecosystem in the Personal Genome Testing Market?
Several market players, through research and development activities, are coming up with innovative strategies to refine genetic testing in clinics. They are also implementing schemes to protect the privacy of their clients’ DNA information.
Emerging players such as 3x4 Genetics, 3billion, CircaGene, Bione, Athletic Genetix, etc. are offering various services such as DNA-based fitness programs, genetic testing for rare diseases, personalized genetic test platforms, microbiome testing, genetic testing for athletes, etc.
What are the Key Developments of the Personal Genome Testing Market?
Some of the key market participants in the personal genome testing market are 23andMe Inc., Navigenics, deCODEme, Color Genomics Inc., Personal Genome Diagnostics Inc., Counsyl, Inc., Quest Diagnostics, Gene By Gene Ltd., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., BGI, MYRIAD GENETICS, INC. (MYRIAD RBM, INC.), Eurofins Scientific, CSL Ltd., Abbott Laboratories, Invitae Corporation, Ambry Genetics, BioReference, Progenity Inc., and others are coming up with new innovations to perfect the extraction of genetic material.
Rising cases of chronic diseases are increasing the adoption of personal genome testing. This is attributed to the growth of key players in the market, which is increasing competitiveness in the market, surging the demand for personal genome testing.
Some Of The Recent Developments In The Personal Genome Testing Market Are
In February 2019, a funding of US$ 22.7 Mn, in addition to funding of US$ 33.4 Mn by provincial governments, was announced by the Minister of Science and Sport (Canada), to support 36 research projects through Genome Canada.
In January 2020, the “Genome India Project” was initiated by the Department of Biotechnology (DBT) to collect 10,000 samples from citizens across India to build a reference genome.
In 2020, QIAGEN acquired NeuMoDx Molecular to strengthen its leadership position in automated molecular testing.
In March 2022, Genome sequencing group Illumina launched a cancer test in Europe that checks for a wide range of tumor genes in one tissue sample, to help patients with rare diseases be matched up with treatment options.
Scope of Report
Report Attribute
Details
Growth Rate
CAGR of 10.1% from 2022 to 2032
Base year for estimation
2021
Historical data
2015 to 2020
Forecast period
2022 to 2032
Quantitative units
Revenue in USD million and CAGR from 2022 to 2032
Report coverage
Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered
Type, Application, and Region.
Regional scope
North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope
USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs.
Key Segments
By Type:
Multi-Targeted Testing
Non-Targeted Testing
Targeted Testing
By Application:
Neurological Disorders
Oncology
Metabolic Disorders
Autoimmune Disorders
By Region:
North America
Latin America
MEA
Asia Pacific
Europe
Frequently Asked Questions
How much CAGR can be Estimated for the Personal Genome Testing Market?
Ans. Personal genome testing is likely to register a CAGR of 10.1% during the forecast period.
What is the Leading Regional Market of Personal Genome Testing?
North America is the leading personal genome testing market, with a revenue share of 37.3%.
What will be the Size of the Personal Genome Testing Market by 2032?
By 2032, the market is likely to grow to a valuation of US$ 4,468 Mn.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Personal Genome Testing Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Personal Genome Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
5.3.1. Neurological Disorders
5.3.2. Oncology
5.3.3. Metabolic Disorders
5.3.4. Autoimmune Disorders
5.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
5.5. Absolute $ Opportunity Analysis By Application, 2022-2032
6. Global Personal Genome Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
6.3.1. Targeted Testing
6.3.2. Non-Targeted Testing
6.3.3. Multi-Targeted Testing
6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
6.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
7. Global Personal Genome Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Personal Genome Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Application
8.2.3. By Product Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Application
8.3.3. By Product Type
8.4. Key Takeaways
9. Latin America Personal Genome Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Application
9.2.3. By Product Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By Product Type
9.4. Key Takeaways
10. Europe Personal Genome Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Application
10.2.3. By Product Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By Product Type
10.4. Key Takeaways
11. Asia Pacific Personal Genome Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. Rest of Asia Pacific
11.2.2. By Application
11.2.3. By Product Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By Product Type
11.4. Key Takeaways
12. MEA Personal Genome Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Application
12.2.3. By Product Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By Product Type
12.4. Key Takeaways
13. Key Countries Personal Genome Testing Market Analysis
13.1. U.K.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Application
13.1.2.2. By Product Type
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Application
13.2.2.2. By Product Type
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Application
13.3.2.2. By Product Type
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Application
13.4.2.2. By Product Type
13.5. Rest of Latin America
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Application
13.5.2.2. By Product Type
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Application
13.6.2.2. By Product Type
13.7. U.K.
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Application
13.7.2.2. By Product Type
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Application
13.8.2.2. By Product Type
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Application
13.9.2.2. By Product Type
13.10. Italy
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Application
13.10.2.2. By Product Type
13.11. Rest of Europe
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Application
13.11.2.2. By Product Type
13.12. China
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Application
13.12.2.2. By Product Type
13.13. Japan
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Application
13.13.2.2. By Product Type
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Application
13.14.2.2. By Product Type
13.15. Malaysia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Application
13.15.2.2. By Product Type
13.16. Singapore
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Application
13.16.2.2. By Product Type
13.17. Australia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Application
13.17.2.2. By Product Type
13.18. Rest of Asia Pacific
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Application
13.18.2.2. By Product Type
13.19. GCC Countries
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Application
13.19.2.2. By Product Type
13.20. South Africa
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2021
13.20.2.1. By Application
13.20.2.2. By Product Type
13.21. Israel
13.21.1. Pricing Analysis
13.21.2. Market Share Analysis, 2021
13.21.2.1. By Application
13.21.2.2. By Product Type
13.22. Rest of MEA
13.22.1. Pricing Analysis
13.22.2. Market Share Analysis, 2021
13.22.2.1. By Application
13.22.2.2. By Product Type
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Application
14.3.3. By Product Type
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. 23andMe, Inc.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Navigenics
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. deCODEme
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Color Genomics, Inc
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Personal Genome Diagnostics, Inc.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Counsyl, Inc.
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Quest Diagnostics,
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Gene By Gene, Ltd.
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. aboratory Corporation of America® Holdings
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. mapmygenome.in
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. Positive Bioscience, Inc
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
16. Assumptions & Acronyms Used17. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Personal Genome Testing Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 3: Global Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 4: North America Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 5: North America Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 6: North America Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 7: Latin America Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Latin America Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 9: Latin America Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 10: Europe Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 12: Europe Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 13: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 15: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 16: MEA Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: MEA Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 18: MEA Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 2: Global Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 3: Global Personal Genome Testing Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Personal Genome Testing Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Personal Genome Testing Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Personal Genome Testing Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 8: Global Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 9: Global Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 10: Global Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 11: Global Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 12: Global Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 13: Global Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 14: Global Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 15: Global Personal Genome Testing Market Attractiveness by Region, 2022-2032
Figure 16: North America Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 17: North America Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 18: North America Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 23: North America Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 24: North America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 25: North America Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 26: North America Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 27: North America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 28: North America Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 29: North America Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 30: North America Personal Genome Testing Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 32: Latin America Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 33: Latin America Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 38: Latin America Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 39: Latin America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 40: Latin America Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 41: Latin America Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 42: Latin America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 43: Latin America Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 44: Latin America Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 45: Latin America Personal Genome Testing Market Attractiveness by Country, 2022-2032
Figure 46: Europe Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 47: Europe Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 48: Europe Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 53: Europe Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 54: Europe Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 55: Europe Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 56: Europe Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 57: Europe Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 58: Europe Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 59: Europe Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 60: Europe Personal Genome Testing Market Attractiveness by Country, 2022-2032
Figure 61: Asia Pacific Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 62: Asia Pacific Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 63: Asia Pacific Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 64: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: Asia Pacific Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: Asia Pacific Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 68: Asia Pacific Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 69: Asia Pacific Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 70: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 71: Asia Pacific Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 72: Asia Pacific Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 73: Asia Pacific Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 74: Asia Pacific Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 75: Asia Pacific Personal Genome Testing Market Attractiveness by Country, 2022-2032
Figure 76: MEA Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 77: MEA Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 78: MEA Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 79: MEA Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: MEA Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: MEA Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: MEA Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 83: MEA Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 84: MEA Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 85: MEA Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 86: MEA Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 87: MEA Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 88: MEA Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 89: MEA Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 90: MEA Personal Genome Testing Market Attractiveness by Country, 2022-2032
